Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Congleton Jon sold 75,000 Mineralys Therapeutics, Inc. shares (Form 4)
Traded Sep 30, 2026 · Filed Oct 2, 2026
On Sep 30, 2026, Congleton Jon (Director, Chief Executive Officer) sold 75,000 Mineralys Therapeutics, Inc. shares at US$25.46 for US$1.91M under a trading plan, leaving 528,621 shares. Filed Oct 2, 2026 (Form 4).
- Sold
- 75,000 shares
- Price
- US$25.46
- Value
- US$1.91M
- Holding after
- 528,621 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Stock | Sale | 75,000 | US$25.46 | 528,621 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Congleton Jon
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Congleton Jon · Jul 15, 2026
- Form 4 · Congleton Jon · Jun 30, 2026
- Form 4 · Congleton Jon · Apr 15, 2026
- Form 4 · Congleton Jon · Apr 2, 2026
- Form 4 · Peterson Kristine · Oct 20, 2026
- Form 4 · Coats Lonnel · Oct 20, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Warren Eric · Sep 22, 2026
- Form 4 · Karydas Daphne · Sep 17, 2026